ZLAB
Zai Lab Ltd
NASDAQ: ZLAB · HEALTHCARE · BIOTECHNOLOGY
$21.64
+4.29% today
Updated 2026-04-30
Market cap
$2.33B
P/E ratio
—
P/S ratio
5.07x
EPS (TTM)
$-1.60
Dividend yield
—
52W range
$16 – $44
Volume
0.8M
Zai Lab Ltd (ZLAB) Financial statements
SEC filings — annual and quarterly data.
Balance sheet — annual
| Item | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | $13.94M | $88.91M | $249.63M | $301.99M | $355.15M | $1.30B | $1.61B | $1.22B | $1.04B | $1.19B |
| Cash & equivalents | — | — | — | — | — | — | — | — | — | — |
| Current assets | $13.23M | $84.09M | $230.61M | $269.14M | $292.46M | $1.22B | $1.50B | $1.12B | $939.61M | $1.05B |
| Total liabilities | $32.31M | $140.46M | $14.46M | $50.91M | $60.49M | $128.29M | $230.00M | $174.54M | $240.18M | $344.86M |
| Current liabilities | $3.94M | $5.17M | $12.07M | $48.84M | $46.63M | $98.04M | $192.90M | $139.84M | $203.07M | $299.38M |
| Long-term debt | — | — | — | — | — | — | — | — | — | — |
| Shareholder equity | — | — | — | — | — | — | — | — | — | — |
| Retained earnings | $-22.66M | $-60.17M | $-110.55M | $-249.63M | $-444.70M | $-713.60M | $-1.42B | $-1.86B | $-2.20B | $-2.45B |
| Accounts receivable | — | — | — | $90000.00 | $3.79M | $5.17M | $54.81M | $48.57M | $65.33M | $89.41M |
| Inventory | — | — | — | $3822.00 | $6.00M | $13.14M | $18.95M | $31.62M | $44.83M | $39.88M |
| Goodwill | — | — | — | — | — | — | — | — | $-1.00 | — |